The ANTKMT Knockout HeLa Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population designed to enable functional interrogation of the ANTKMT gene. This model provides a loss-of-function system for studying adenine nucleotide translocator lysine methyltransferase, a critical enzyme that methylates mitochondrial adenine nucleotide translocators, thereby regulating ATP/ADP exchange and cellular energy balance. As a polyclonal pool, these cells retain population heterogeneity, reflecting the average knockout effect across diverse editing events without clonal isolation.
The host HeLa cell line is an immortalized human cervical adenocarcinoma line harboring HPV18 sequences, renowned for its robust growth and utility in cancer biology, virology, and metabolic research. HeLa cells exhibit high mitochondrial respiration and glycolytic flux, making them an ideal system for investigating mitochondrial transporters and post-translational control mechanisms, including protein methylation. Their genetic tractability and well-characterized physiology support advanced gene-editing applications.
ANKTMT catalyzes the lysine methylation of ANT proteins??SLC25A4 (ANT1), SLC25A5 (ANT2), and SLC25A6 (ANT3)??modifying their activity to modulate the mitochondrial adenine nucleotide translocator function. This methylation is responsive to upstream metabolic stress signals and the NADH/NAD+ ratio, linking cellular redox state to mitochondrial ATP export. ANTKMT directly interacts with these ANT isoforms and is functionally connected to protein arginine methyltransferases, placing it at a nexus of metabolic and epigenetic regulation. Disruption of this methylation can impair nucleotide exchange efficiency, potentially altering mitochondrial respiration and ATP synthesis.
In HeLa cells, ANTKMT knockout may profoundly impact mitochondrial energy metabolism by reducing ANT methylation, leading to imbalanced ADP/ATP exchange. This perturbation could reshape cellular bioenergetics, influencing pathways such as oxidative phosphorylation and glycolysis that are often deregulated in cancer. The model thus serves as a physiologically relevant platform to dissect how mitochondrial epigenetic modifications contribute to metabolic disorders, mitochondrial diseases, and tumorigenic phenotypes.
This knockout tool is applicable in cancer metabolism research, mitochondrial function studies, and drug target validation for metabolic disorders. Experimental approaches include Western blotting for ANT methylation status, Seahorse-based oxygen consumption rate (OCR) assays, ATP production measurements, co-immunoprecipitation to detect ANTKMT-ANT interactions, and mass spectrometry for methyl-site mapping. These assays enable detailed characterization of ANTKMT??s role in mitochondrial nucleotide transport and cellular energy homeostasis. For further information, please contact Ascent Research.
